[HTML][HTML] Lipoprotein (a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene

S Coassin, F Kronenberg - Atherosclerosis, 2022 - Elsevier
Abstract High lipoprotein (a)[Lp (a)] concentrations are one of the most important genetically
determined risk factors for cardiovascular disease. Lp (a) concentrations are an enigmatic …

Lipoprotein (a) in health and disease

F Kronenberg, A Steinmetz, GM Kostner… - Critical reviews in …, 1996 - Taylor & Francis
Abstract Lipoprotein (a)[Lp (a)] represents an LDL-like particle to which the Lp (a)-specific
apolipoprotein (a) is linked via a disulfide bridge. It has gained considerable interest as a …

Lipoprotein (a) serum concentrations and apolipoprotein (a) phenotypes in mild and moderate renal failure

F Kronenberg, E Kuen, E Ritz, R Junker… - Journal of the …, 2000 - journals.lww.com
Abstract High lipoprotein (a)(Lp (a)) serum concentrations and the underlying apolipoprotein
(a)(apo (a)) phenotypes are risk factors for cardiovascular disease in the general population …

Lipoprotein (a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature

E Paige, KL Masconi, S Tsimikas, F Kronenberg… - Cardiovascular …, 2017 - Springer
Aims We aimed to (1) assess the association between lipoprotein (a)[Lp (a)] concentration
and incident type-2 diabetes in the Bruneck study, a prospective population-based study …

Farnesoid X receptor represses hepatic human APOA gene expression

I Chennamsetty, T Claudel, KM Kostner… - The Journal of …, 2011 - Am Soc Clin Investig
High plasma concentrations of lipoprotein (a)[Lp (a), which is encoded by the APOA gene]
increase an individual's risk of developing diseases, such as coronary artery diseases …

The low molecular weight apo (a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up

F KRONENBERG, U NEYER, K LHOTTA… - Journal of the …, 1999 - journals.lww.com
Patients with end-stage renal disease treated by hemodialysis have a tremendous risk for
cardiovascular complications that cannot be explained by traditional atherosclerosis risk …

Renovascular arteriovenous differences in Lp [a] plasma concentrations suggest removal of Lp [a] from the renal circulation

F Kronenberg, E Trenkwalder, A Lingenhel… - Journal of lipid …, 1997 - ASBMB
High plasma concentrations of lipoprotein [a](Lp [a]) are considered a genetically
determined risk factor for atherosclerosis. Lp [a] is produced by the liver. The site (s) and …

Association of serum lipoprotein (a) levels and apolipoprotein (a) size polymorphism with target-organ damage in arterial hypertension

LA Sechi, F Kronenberg, S De Carli, E Falleti, L Zingaro… - Jama, 1997 - jamanetwork.com
Objective.—To investigate the association between lipoprotein (a)[Lp (a)] and other plasma
lipids and apolipoproteins and target-organ damage (TOD) in patients with arterial …

Analysis of the apo (a) size polymorphism in Asian Indian populations: association with Lp (a) concentration and coronary heart disease

FS Geethanjali, K Luthra, A Lingenhel… - Atherosclerosis, 2003 - Elsevier
Most studies aiming to detect associations of genetic variation with common complex
diseases, eg coronary heart disease (CHD) have been performed in populations with a …

Lipoprotein (a): A Case for Universal Screening in Youth

A Alankar, PC Brar, B Kohn - Current Atherosclerosis Reports, 2023 - Springer
Abstract Purpose of Review Lipoprotein (a) has emerged as a strong independent risk factor
for cardiovascular disease. Targeted screening recommendations for Lp (a) measurement …